Literature DB >> 4029016

Renal clearance of temocillin in volunteers.

D Overbosch, C van Gulpen, H Mattie.   

Abstract

After administration of a loading dose, temocillin was infused intravenously into 5 volunteers for 3 hours (250 and 750 mg/h). A urine flow of more than 500 ml/h was maintained. The mean plasma concentrations were 131.4 and 220.7 mg/L during the lower dose and higher dose infusions, respectively, and protein binding decreased from 83% to 74% with this increase in plasma concentration. The renal clearance of the total drug increased from 29.0 ml/min (low dose) to 50.5 ml/min (high dose) [p less than 0.001], but after correction for protein binding the renal clearance of the unbound drug only increased from 169.1 to 197.0 ml/min (not statistically significant). The extrarenal clearance of temocillin was negligible. Blocking of tubular excretion by probenecid caused a maximum decrease of the renal clearance of temocillin from 34.1 to 22.4 ml/min. This maximum effect of 12.3 ml/min subsided by 1.7 ml/min/h. The renal clearance of the free drug decreased to 134.6 ml/min, slightly less than the creatinine clearance (158.1 ml/min). It may be concluded that even at high plasma concentrations of temocillin there is no saturation of the tubular transport mechanism, and that tubular excretion plays a relatively minor role in the renal excretion of the drug.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4029016     DOI: 10.2165/00003495-198500295-00027

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  19 in total

1.  THE RENAL CLEARANCE OF PENICILLINS F, G, K, AND X IN RABBITS AND MAN.

Authors:  H Eagle; E Newman; A D Musselman; M Robinson; M Birmingham
Journal:  J Clin Invest       Date:  1947-09       Impact factor: 14.808

2.  Dose-dependent pharmacokinetics of azlocillin compared to mezlocillin.

Authors:  T Bergan; S B Thorsteinsson; O Steingrimsson
Journal:  Chemotherapy       Date:  1982       Impact factor: 2.544

3.  Temocillin compared to ampicillin against Haemophilus influenzae and with other penicillins against intestinal aerobic Gram-negative rods.

Authors:  H Y Chen; J D Williams
Journal:  J Antimicrob Chemother       Date:  1982-10       Impact factor: 5.790

4.  Temocillin elimination in patients with varying degrees of renal failure.

Authors:  N Wright; R Wise; J D Price
Journal:  J Antimicrob Chemother       Date:  1983-05       Impact factor: 5.790

5.  Comparative in vitro study of temocillin (BRL 17421), a new penicillin.

Authors:  R Bolivar; S S Weaver; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

6.  Temocillin (BRL 17421): in-vitro antibacterial activity and susceptibility to beta-lactamases.

Authors:  I Phillips; A King; K Shannon; C Warren
Journal:  J Antimicrob Chemother       Date:  1982-10       Impact factor: 5.790

7.  In vitro activity of temocillin (BRL 17421), a novel beta-lactamase-stable penicillin.

Authors:  L Verbist
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

8.  Dicloxacillin and cloxacillin: pharmacokinetics in healthy and hemodialysis subjects.

Authors:  E H Nauta; H Mattie
Journal:  Clin Pharmacol Ther       Date:  1976-07       Impact factor: 6.875

9.  Comparative in vitro activities of temocillin and cefazolin against Klebsiella pneumoniae.

Authors:  H Lagast; J Klastersky
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

10.  In vitro activity of temocillin (BRL 17421), a novel beta-lactam antibiotic.

Authors:  H W Van Landuyt; M Pyckavet; A Lambert; J Boelaert
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

View more
  7 in total

Review 1.  Pharmacokinetics and Pharmacodynamics of Temocillin.

Authors:  Kevin Alexandre; Bruno Fantin
Journal:  Clin Pharmacokinet       Date:  2018-03       Impact factor: 6.447

2.  The effect of probenecid on the renal tubular excretion of benzylpenicillin.

Authors:  D Overbosch; C Van Gulpen; J Hermans; H Mattie
Journal:  Br J Clin Pharmacol       Date:  1988-01       Impact factor: 4.335

3.  Effect of protein binding on penetration of beta-lactams into rabbit peripheral lymph.

Authors:  G Woodnutt; V Berry; L Mizen
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

4.  Modelled Target Attainment after Temocillin Treatment in Severe Pneumonia: Systemic and Epithelial Lining Fluid Pharmacokinetics of Continuous versus Intermittent Infusions.

Authors:  N Layios; C Visée; V Mistretta; R Denooz; N Maes; J Descy; F Frippiat; S Marchand; N Grégoire
Journal:  Antimicrob Agents Chemother       Date:  2022-01-31       Impact factor: 5.938

5.  Temocillin efficacy in experimental Klebsiella pneumoniae meningitis after infusion into rabbit plasma to simulate antibiotic concentrations in human serum.

Authors:  G Woodnutt; E J Catherall; I Kernutt; L Mizen
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

Review 6.  Temocillin: Applications in Antimicrobial Stewardship as a Potential Carbapenem-Sparing Antibiotic.

Authors:  Tommaso Lupia; Ilaria De Benedetto; Giacomo Stroffolini; Stefano Di Bella; Simone Mornese Pinna; Verena Zerbato; Barbara Rizzello; Roberta Bosio; Nour Shbaklo; Silvia Corcione; Francesco Giuseppe De Rosa
Journal:  Antibiotics (Basel)       Date:  2022-04-07

7.  Population Pharmacokinetics of Temocillin Administered by Continuous Infusion in Patients with Septic Shock Associated with Intra-Abdominal Infection and Ascitic Fluid Effusion.

Authors:  Perrin Ngougni Pokem; Xavier Wittebole; Christine Collienne; Hector Rodriguez-Villalobos; Paul M Tulkens; Laure Elens; Françoise Van Bambeke; Pierre-François Laterre
Journal:  Antibiotics (Basel)       Date:  2022-07-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.